{
    "2020-10-29": [
        [
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)第三季度归母净利润同比增长0.49%至1.74亿元",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "第三季度",
                        "归母净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：前三个季度净利润同比增长0.58%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "前三个季度",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国元医药|点评】康泰生物2020年三季报点评：创新苗持续放量，研发梯队有序推进",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "三季报",
                        "创新苗",
                        "研发梯队"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫苗股高举高打，智飞生物涨超10%",
                "features": {
                    "keywords": [
                        "疫苗股",
                        "智飞生物",
                        "涨超10%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中医药将进入高速发展黄金时期，这些医药股龙头值得关注",
                "features": {
                    "keywords": [
                        "中医药",
                        "高速发展",
                        "医药股龙头"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】《康泰生物点评报告：四联苗包装升级，重磅产品陆续获批》",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "包装升级",
                        "重磅产品",
                        "获批"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "解码7788份公募基金三季报：“吃药喝酒”仍为主流，明星基金经理持仓分化",
                "features": {
                    "keywords": [
                        "公募基金",
                        "三季报",
                        "吃药喝酒",
                        "持仓分化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}